Have a feature idea you'd love to see implemented?
Let us know!
AVNS Avanos Medical Inc
Price (delayed)
$23.21
Market cap
$1.07B
P/E Ratio
136.53
Dividend/share
N/A
EPS
$0.17
Enterprise value
$1.19B
Avanos Medical, Inc. is a medical technology company focused on delivering clinical medical device solutions. The company consists of two franchises – Pain Management and Chronic Care – that address
Highlights
The EPS has soared by 122% YoY and by 113% from the previous quarter
The net income has soared by 121% YoY and by 112% from the previous quarter
The quick ratio has declined by 29% year-on-year
The gross profit has contracted by 2.9% YoY
Key stats
What are the main financial stats of AVNS
Market
Valuations
Earnings
Shares outstanding
45.95M
Market cap
$1.07B
Enterprise value
$1.19B
Price to earnings (P/E)
136.53
Price to book (P/B)
0.87
Price to sales (P/S)
1.56
EV/EBIT
41.27
EV/EBITDA
16.09
EV/Sales
1.75
Revenue
$682.4M
EBIT
$28.9M
EBITDA
$74.1M
Free cash flow
$41.8M
Per share
Balance sheet
Liquidity
EPS
$0.17
Free cash flow per share
$0.91
Book value per share
$26.62
Revenue per share
$14.87
TBVPS
$13.88
Total assets
$1.66B
Total liabilities
$435.8M
Debt
$218.3M
Equity
$1.22B
Working capital
$265.9M
Debt to equity
0.18
Current ratio
2.28
Quick ratio
1.03
Net debt/EBITDA
1.7
Margins
Efficiency
Dividend
EBITDA margin
10.9%
Gross margin
55.8%
Net margin
1.1%
Operating margin
5.4%
Return on assets
0.5%
Return on equity
0.6%
Return on invested capital
4.8%
Return on capital employed
2%
Return on sales
4.2%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
AVNS stock price
How has the Avanos Medical stock price performed over time
Intraday
0.83%
1 week
-2.36%
1 month
-2.93%
1 year
16.57%
YTD
3.48%
QTD
-3.41%
Financial performance
How have Avanos Medical's revenue and profit performed over time
Revenue
$682.4M
Gross profit
$380.9M
Operating income
$37M
Net income
$7.7M
Gross margin
55.8%
Net margin
1.1%
Avanos Medical's net margin has soared by 121% YoY and by 112% from the previous quarter
The net income has soared by 121% YoY and by 112% from the previous quarter
Avanos Medical's operating margin has soared by 50% YoY and by 38% from the previous quarter
The operating income is up by 49% YoY and by 39% QoQ
Growth
What is Avanos Medical's growth rate over time
Valuation
What is Avanos Medical stock price valuation
P/E
136.53
P/B
0.87
P/S
1.56
EV/EBIT
41.27
EV/EBITDA
16.09
EV/Sales
1.75
The EPS has soared by 122% YoY and by 113% from the previous quarter
AVNS's price to book (P/B) is 21% less than its 5-year quarterly average of 1.1 but 9% more than its last 4 quarters average of 0.8
The P/S is 26% lower than the 5-year quarterly average of 2.1 but 11% higher than the last 4 quarters average of 1.4
Efficiency
How efficient is Avanos Medical business performance
AVNS's ROIC has soared by 170% from the previous quarter
The ROS has soared by 166% from the previous quarter
The return on assets has surged by 124% year-on-year and by 114% since the previous quarter
The ROE has soared by 121% YoY and by 112% from the previous quarter
Dividends
What is AVNS's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for AVNS.
Financial health
How did Avanos Medical financials performed over time
The quick ratio has declined by 29% year-on-year
The company's current ratio fell by 28% YoY
Avanos Medical's debt is 82% less than its equity
The debt to equity has contracted by 14% YoY but it has grown by 6% from the previous quarter
Avanos Medical's debt has decreased by 14% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.